In gliomas, elevated YTHDF2 expression could suppress the expression of LXRα and HIVEP2 via m6A-dependent mRNA clearance, which is required for GSC growth, invasion, and tumor formation in vivo [19]. Here, YTHDF2 is linked to central nervous system cancer.